NCT02839200: A reported trial by Idorsia Pharmaceuticals Ltd.
This trial has reported on time, in line with the regulations.
Full data
Full entry on ClinicalTrials.gov | NCT02839200 |
---|---|
Title | Multi-center, Double-blind, Randomized, Placebo-controlled, Active-reference, Parallel-group, Polysomnography Dose-response Study to Assess the Efficacy and Safety of ACT-541468 in Adult Subjects With Insomnia Disorder |
Results Status | Reported |
ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
Start date | Oct. 4, 2016 |
Completion date | April 12, 2017 |
Required reporting date | April 12, 2020, midnight |
Actual reporting date | March 6, 2020 |
Date last checked at ClinicalTrials.gov | Feb. 9, 2024 |
Days late | None |